Page last updated: 2024-08-17

egtazic acid and quinelorane

egtazic acid has been researched along with quinelorane in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alpini, G; Alvaro, D; Barbaro, B; Francis, H; Glaser, S; LeSage, G; Mancino, MG; Marzioni, M; Mauldin, J; Phinizy, JL; Rashid, S; Roskams, T; Stoica, G; Ueno, Y	1
Bargas, J; Galarraga, E; Perez-Burgos, A; Perez-Garci, E; Perez-Rosello, T; Salgado, H; Tecuapetla, F	1

Other Studies

2 other study(ies) available for egtazic acid and quinelorane

Article	Year
Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity. American journal of physiology. Gastrointestinal and liver physiology, 2003, Volume: 284, Issue:4 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetophenones; Alkaloids; Animals; Benzophenanthridines; Benzopyrans; Bicarbonates; Bile; Bile Ducts, Intrahepatic; Chelating Agents; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Agonists; Down-Regulation; Egtazic Acid; Enzyme Inhibitors; Epithelium; Liver; Male; Phenanthridines; Protein Kinase C; Quinolines; Rats; Rats, Inbred F344; Receptors, Dopamine D2; Secretin	2003
A reconfiguration of CaV2 Ca2+ channel current and its dopaminergic D2 modulation in developing neostriatal neurons. Journal of neurophysiology, 2005, Volume: 94, Issue:6 Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Calcium; Calcium Channel Blockers; Caveolin 2; Chelating Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Egtazic Acid; Electric Stimulation; Membrane Potentials; Neostriatum; Neurons; Patch-Clamp Techniques; Quinolines; Rats; Rats, Wistar; Receptors, Dopamine D2; Time Factors	2005

Article

Year

Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity.

American journal of physiology. Gastrointestinal and liver physiology, 2003, Volume: 284, Issue:4

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetophenones; Alkaloids; Animals; Benzophenanthridines; Benzopyrans; Bicarbonates; Bile; Bile Ducts, Intrahepatic; Chelating Agents; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Agonists; Down-Regulation; Egtazic Acid; Enzyme Inhibitors; Epithelium; Liver; Male; Phenanthridines; Protein Kinase C; Quinolines; Rats; Rats, Inbred F344; Receptors, Dopamine D2; Secretin

2003

A reconfiguration of CaV2 Ca2+ channel current and its dopaminergic D2 modulation in developing neostriatal neurons.

Journal of neurophysiology, 2005, Volume: 94, Issue:6

Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Calcium; Calcium Channel Blockers; Caveolin 2; Chelating Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Egtazic Acid; Electric Stimulation; Membrane Potentials; Neostriatum; Neurons; Patch-Clamp Techniques; Quinolines; Rats; Rats, Wistar; Receptors, Dopamine D2; Time Factors

2005